Skip to main content
. Author manuscript; available in PMC: 2021 Aug 6.
Published in final edited form as: J Am Coll Cardiol. 2019 Mar 17;74(10):1376–1414. doi: 10.1016/j.jacc.2019.03.009

Recommendations for Treatment of Tobacco Use

Referenced studies that support recommendations are summarized in Online Data Supplements 15 and 16.

COR LOE RECOMMENDATIONS
I A 1. All adults should be assessed at every healthcare visit for tobacco use and their tobacco use status recorded as a vital sign to facilitate tobacco cessation (S4.5-1).
I A 2. To achieve tobacco abstinence, all adults who use tobacco should be firmly advised to quit (S4.5-2).
I A 3. In adults who use tobacco, a combination of behavioral interventions plus pharmacotherapy is recommended to maximize quit rates (S4.5-2,S4.5-3).
I B-NR 4. In adults who use tobacco, tobacco abstinence is recommended to reduce ASCVD risk (S4.5-4,S4.5-5).
IIa B-R 5. To facilitate tobacco cessation, it is reasonable to dedicate trained staff to tobacco treatment in every healthcare system (S4.5-1).
III: Harm B-NR 6. All adults and adolescents should avoid secondhand smoke exposure to reduce ASCVD risk (S4.5-6).